ImmuCell Corporation (ICCC): Price and Financial Metrics

ImmuCell Corporation (ICCC)

Today's Latest Price: $6.00 USD

0.16 (2.74%)

Updated Nov 27 12:49pm

Add ICCC to Watchlist
Sign Up

Overall POWR Rating

POWR Components:

 Trade Grade  Buy & Hold Grade  Peer Grade  Industry Rank

Industry Rank:

Ranked of 369 in Miscellaneous

See all "A" rated Strong Buy stocks

ICCC Stock Summary

  • ICCC has a higher market value than only 12.72% of US stocks; more precisely, its current market capitalization is $42,123,447.
  • Price to trailing twelve month operating cash flow for ICCC is currently 37.86, higher than 89.01% of US stocks with positive operating cash flow.
  • Equity multiplier, or assets relative to shareholders' equity, comes in at 1.39 for Immucell Corp; that's greater than it is for only 20.2% of US stocks.
  • Stocks with similar financial metrics, market capitalization, and price volatility to Immucell Corp are OIIM, MOSY, APVO, ADTN, and RIGL.
  • ICCC's SEC filings can be seen here. And to visit Immucell Corp's official web site, go to

ICCC Stock Price Chart Interactive Chart >

Price chart for ICCC

ICCC Price/Volume Stats

Current price $6.00 52-week high $8.13
Prev. close $5.84 52-week low $3.70
Day low $5.73 Volume 43,400
Day high $6.10 Avg. volume 37,638
50-day MA $5.60 Dividend yield N/A
200-day MA $5.06 Market Cap 43.28M

ICCC Latest News Stream

Event/Time News Detail
Loading, please wait...

ICCC Latest Social Stream

Loading social stream, please wait...

View Full ICCC Social Stream

Latest ICCC News From Around the Web

Below are the latest news stories about Immucell Corp that investors may wish to consider to help them evaluate ICCC as an investment opportunity.

ImmuCell Corporation 2020 Q2 - Results - Earnings Call Presentation

The following slide deck was published by ImmuCell Corporation in conjunction with their 2020 Q2 earnings call....

SA Transcripts on Seeking Alpha | August 13, 2020

Portland-based ImmuCell reports increased revenue, net loss for second quarter

The bovine health products maker reported sales of $3 million and a net loss of $766,000 for the quarter ending June 30.

Portland Press Herald | August 13, 2020

ImmuCell EPS misses by $0.01, misses on revenue

ImmuCell (ICCC): Q2 GAAP EPS of -$0.11 misses by $0.01.Revenue of $2.97M (+9.6% Y/Y) misses by $0.03M."We reduced the backlog of orders to ~$945K as of June 30, 2020 from ~$1.4M as of March 31, 2020. The investment to increase our First Defense production capacity remains on budget and close to...

Seeking Alpha | August 12, 2020

ImmuCell Announces Unaudited Financial Results for the Second Quarter Ended June 30, 2020

PORTLAND, Maine, Aug. 12, 2020 (GLOBE NEWSWIRE) -- ImmuCell Corporation (Nasdaq: ICCC) (“ImmuCell” or the “Company”), a growing animal health company…

GlobeNewswire | August 12, 2020

ImmuCell to Announce Unaudited Financial Results for Second Quarter of 2020

Conference Call Scheduled for Thursday, August 13, 2020 at 9:00 AM ET

GlobeNewswire | August 6, 2020

Read More 'ICCC' Stories Here

ICCC Price Returns

1-mo 15.16%
3-mo 17.88%
6-mo 36.36%
1-year 20.00%
3-year -32.58%
5-year -21.05%
YTD 16.50%
2019 -26.95%
2018 -19.80%
2017 47.73%
2016 N/A
2015 0.00%

Continue Researching ICCC

Want to see what other sources are saying about Immucell Corp's financials and stock price? Try the links below:

Immucell Corp (ICCC) Stock Price | Nasdaq
Immucell Corp (ICCC) Stock Quote, History and News - Yahoo Finance
Immucell Corp (ICCC) Stock Price and Basic Information | MarketWatch

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!

Page generated in 0.7649 seconds.